Skip to main content

Table 1 Baseline characteristics of patients who received chemotherapy

From: Objective evaluation of oxaliplatin-induced vascular pain secondary to peripheral vein administration

 

N (%)

Mean

SD

Range

Mean age, years

 

65.2

8.6

43–80

Gender

Male

40 (69.0)

   

Female

18 (31.0)

   

Chemotherapy

XELOX

18 (31.0)

   

XELOX + BV

40 (69.0)

   

ECOG PS

0

47 (81.0)

   

1

11 (19.0)

   

2

0 (0)

   

3

0 (0)

   

Primary cancer

Colon

31 (53.4)

   

Rectum

27 (46.6)

   

Adverse events (Grade 34)

Hematological

7 (12.1)

   

Non-hematological

10 (17.2)

   

Oxaliplatin (mg/body)

 

1751

136.6

345–5903